COVID-19 vaccine reinforcement authorized in children from 5 to 11


The Food and Drug Administration (FDA) authorized this Tuesday, May 17, the expansion of eligibility for the Pfizer-BioNTech COVID-19 booster dose for children 5 to 11 years of age.

As it is in the public domain, on January 3 of this year, the federal agency had authorized the application of a single booster dose to be administered to people aged 12 to 15 years, “after completing the primary vaccination with the vaccine” mentioned above. .

Peter Marks, MD, director of the Center for Biological Evaluation and Research, “Pfizer-BioNTech’s COVID-19 vaccine is effective in helping prevent the most serious consequences (of coronavirus) in people 5 years of age and older. ”.

The federal agency indicated that “since the vaccine was authorized for children under 5 years of age (of age) in October 2021, emerging data suggests that the efficacy of the vaccine against COVID-19 decreases after the second dose of the vaccine. vaccine in all authorized populations.

“They overcome risks known and potential

He added in the same sense that “the FDA has determined that the known and potential benefits of a single booster dose of the Pfize-BioNTech COVID-19 vaccine for children 5 to 11 years of age, at least five months after completing a primary series outweigh their known and potential risks.

Likewise, he specified, “the booster dose can help provide continuous protection against COVID-19 in this age group and in the elderly.”

According to the FDA “since the vaccine was licensed for children under 5 years of age in October 2021, emerging data suggest that the efficacy of the vaccine (against the virus) declines after the second dose of the vaccine in all authorized populations” (or eligible).

Omicron, an enemy that threatens infants

For his part, FDA Commissioner Robert M. Califf, MD, “While it has largely been the case that COVID-19 tends to be less severe in children than in adults, the wave of omicron has seen more children get sick with the disease and be hospitalized, and children may also experience longer-term effects, even after (being) initially mildly ill.” And the FDA concludes that “vaccination remains the most effective way to prevent COVID-19 and its serious consequences, and it is safe. If your child is eligible for the Pfizer-BioNtech COVID-19 vaccine and has not yet received their primary series, vaccinating them can help protect them from potentially serious consequences such as hospitalization and death.”

Comments are closed.